Question in the title, detail here: can we stop arguing about cloned site until somebody posts a number. Reported something here with dates and screenshots and was…
u/quiet_moderator
I remove the obvious stuff so you never see it. Message the modmail, not me.
moderator · mod · joined 19 Sep 2023
Overview — page 2 of 3
comment on [Meta] can we get an auto-reply for "what dose should i be on" in c/semaglutide · 9 points · 1 months ago
stalling at 0.5mg is information, not a verdict
comment on retatrutide is the most under-discussed thing on this board in c/retatrutide · 35 points · 1 months ago
Agreed on the heart-rate reports. They are consistent enough across the threads to be worth noting, not enough to be a finding.
comment on [Rules] no referral links. not once. not ever. permanent. in c/meta · 44 points · 1 months ago
Reminder that no referral or affiliate links are permitted anywhere, from anybody, ever.
comment on [Question] nausea — what am I missing here in c/sideeffects · 37 points · 1 months ago
Flair set to Question. Also the standing reminder that nothing on this board is medical advice.
comment on [Lab] split one vial across PeptideMeter and VendorInvestigate — 98.4% and 97.2% in c/tirzepatide · 44 points · 1 months ago
the appetite effect is blunter than sema, in a good way, most weeks
comment on [Lab] split one vial across PeptideMeter and VendorInvestigate — 98.4% and 97.2% in c/tirzepatide · 200 points · 1 months ago
This is the fifth "should I go up" post today and they are all welcome — but no member here can answer it for you.
comment on why does nobody talk about SURPASS in c/tirzepatide · 320 points · 1 months ago
What step are you on and how long have you been there?
Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.
comment on constipation: what the trials say vs what this community says in c/sideeffects · 5 points · 1 months ago
Are you eating in the couple of hours before you sleep?
comment on what would you tell week-1 you about GIP in c/tirzepatide · 138 points · 1 months ago
This is the fifth "should I go up" post today and they are all welcome — but no member here can answer it for you.
comment on Canada is the most under-discussed thing on this board in c/glp1canada · 9 points · 1 months ago
Agreed. Province first — coverage is a provincial decision and national answers are wrong somewhere by construction.
comment on API source — 17 things I got wrong before I got it right in c/compounding · 77 points · 2 months ago
Left up. It describes an arrangement with specifics and it is honest about the jurisdiction.
comment on nobody warned me about muscle cramps and I would have liked the warning in c/tirzepatide · 18 points · 2 months ago
Held 7.5 for five months. Everyone kept asking when I was going to 10. The answer was never, because 7.5 was working.
comment on 12 months in and orforglipron is still the thing I get wrong in c/orforglipron · 7 points · 2 months ago
Same view. The analytical problem is different enough that the usual purity discussions here do not transfer cleanly.
comment on [Discussion] can we stop arguing about cloned site until somebody posts a number in c/scamalerts · 65 points · 2 months ago
no batch number, no date, no method — that is the pattern, not one detail
comment on dose escalation is the most under-discussed thing on this board in c/retatrutide · 1 points · 2 months ago
That is body weight change, not fat mass. The trials report the first and people quote it as the second.
comment on [Discussion] can we stop arguing about cloned site until somebody posts a number in c/scamalerts · 41 points · 2 months ago
Is this a shop, a group buy, or an individual reseller? They fail in different ways.
comment on [Discussion] can we stop arguing about cloned site until somebody posts a number in c/scamalerts · 29 points · 2 months ago
Bulk Peptide Wholesale gets named here constantly and there is nothing verifiable on file either way
comment on state board — 3 things I got wrong before I got it right in c/compounding · -23 points · 2 months ago
the label on a compounded vial is a legal document, read it
comment on genuine question about sulphur burps that I am slightly embarrassed to ask in c/sideeffects · 2 points · 2 months ago
Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.
comment on dose escalation is the most under-discussed thing on this board in c/retatrutide · 5 points · 2 months ago
small trial, big effect, wide error bars
comment on why does nobody talk about non-peptide in c/orforglipron · 3 points · 2 months ago
Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.
comment on why does nobody talk about gallbladder in c/sideeffects · 146 points · 3 months ago
Removed the specific recommendation. Describe your own experience here; do not tell another member what to take or what dose to be on.
comment on [Lab] split one vial across Janoshik and Medutest — 99.2% and 96.2% in c/tirzepatide · 260 points · 3 months ago
Removed the conversion table. There is no published equivalence between the two molecules and posting one as fact is exactly the kind of thing that gets copied for years.
comment on [PSA] SURPASS is not what most of this community thinks it is in c/tirzepatide · 1 points · 3 months ago
switching from sema is not a dose conversion, there is no clean equivalence
comment on how much of what we believe about dose escalation actually comes from glucagon threads in c/retatrutide · 268 points · 3 months ago
The standing caveat, written out properly because it keeps getting compressed into a footnote.
Nothing containing this compound is approved by any regulator. Research-use-only material is not approved for human use. That is not a legal formality on this board — it is why there is so little independent data, why the escalation schedules people post are invented, and why nobody here can answer a dosing question.
What this board can usefully do is read the published trials carefully, log independent purity results, and be honest about how thin the evidence base is. Everything else belongs somewhere with a clinician in it.
comment on 6 months in and sulphur burps are still the thing I get wrong in c/sideeffects · 273 points · 3 months ago
Flair set to Question. Also the standing reminder that nothing on this board is medical advice.
comment on unpopular opinion: most of what gets said here about 15mg is guesswork in c/tirzepatide · 33 points · 3 months ago
Removed the conversion table. There is no published equivalence between the two molecules and posting one as fact is exactly the kind of thing that gets copied for years.
comment on [Question] how do you actually verify disclosure in c/meta · 16 points · 3 months ago
Moved to modmail. Individual removals get a specific answer there rather than a public thread.
comment on unpopular opinion: most of what gets said here about telehealth is guesswork in c/compounding · 12 points · 3 months ago
Agreed. The 503A versus 503B distinction changes who is allowed to make what, and almost every confused thread here starts by ignoring it.
comment on 4 months in and plateau is still the thing I get wrong in c/semaglutide · 50 points · 3 months ago
I would push back gently. Going up because the scale paused is the single most common mistake described on this board.
comment on Zepbound — my 8-week log, condensed into one table in c/tirzepatide · 117 points · 3 months ago
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
comment on does 503B actually matter or is it forum lore at this point in c/compounding · 9 points · 3 months ago
Removed the staff name. Facilities and clinics can be named here; individuals cannot.
comment on [Results] 45 weeks, 14kg, and tirzepatide was the hard part in c/tirzepatide · 44 points · 4 months ago
2.5 is the starter dose and it is not meant to be the dose that works
comment on [Lab] 21th independent test on WWB — 99.6% on a claimed 99.0%, and the trend is the interesting part in c/tirzepatide · 305 points · 4 months ago
The four-week interval in the label is a minimum.
Saving this one. It is the clearest statement of the stall problem I have read here.
comment on why does nobody talk about reflux in c/sideeffects · 3 points · 4 months ago
Removed the specific recommendation. Describe your own experience here; do not tell another member what to take or what dose to be on.
comment on [Discussion] state board is doing more work than we give it credit for in c/compounding · 84 points · 4 months ago
I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.
comment on Mounjaro: the version I wish someone had shown me in week 1 in c/tirzepatide · 1 points · 4 months ago
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
comment on [Discussion] the province advice in here is 3 years out of date in c/glp1canada · 38 points · 5 months ago
Provincial plan, employer plan, or paying cash?
comment on 8 months in and orforglipron is still the thing I get wrong in c/orforglipron · 1 points · 5 months ago
I would not assume the tolerability profile transfers exactly. Similar class effects, different exposure profile.